Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
Sponsor: N-Power Medicine
Summary
The objective of this study is to build a prospective cohort in patients with locally advanced or metastatic NSCLC with common EGFR mutations. In NPM-002, there will be standardized data collection at baseline, on-treatment and at discontinuation of therapy. Patients who enroll prior to initiation of osimertinib treatment (\~30%) will undergo imaging with standardized intervals.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
130
Start Date
2025-06-05
Completion Date
2029-04
Last Updated
2026-09-22
Healthy Volunteers
No
Conditions
Locations (10)
Pacific Cancer Care
Monterey, California, United States
Torrance Memorial Physician Network-Cancer Care
Torrance, California, United States
John Muir Health
Walnut Creek, California, United States
Bayhealth Cancer Center- Kent
Dover, Delaware, United States
Bayhealth Cancer Center- Sussex
Milford, Delaware, United States
Kootenai Clinic Cancer Services Coeur d'Alene
Coeur d'Alene, Idaho, United States
Northwest Oncology & Hematology
Elk Grove Village, Illinois, United States
New Mexico Oncology Hematology Consultants
Albuquerque, New Mexico, United States
Lankenau Medical Center
Paoli, Pennsylvania, United States
Oncology Consultants, P.A.
Houston, Texas, United States